Research ArticleOpen AccessGoogle Scholar indexed
Post-Vaccination Myasthenia Gravis and Vaquez Disease
Neurology Department of the Pikine Hospital, Dakar, Senegal
Neurology Department, Fann Teaching Hospital, Dakar, Senegal
Infectious Diseases Department, Fann University Hospital Center, Dakar, Senegal
Neurology Department of the Pikine Hospital, Dakar, Senegal
Neurology Department of the Pikine Hospital, Dakar, Senegal
- 1 Neurology Department of the Pikine Hospital, Dakar, Senegal
- 2 Neurology Department, Fann Teaching Hospital, Dakar, Senegal
- 3 Infectious Diseases Department, Fann University Hospital Center, Dakar, Senegal
- 4 Neurology Department of the Pikine Hospital, Dakar, Senegal
- 5 Neurology Department of the Pikine Hospital, Dakar, Senegal
Neuroscience and Medicine·Volume 16 (2025)·Pages 102–106·Published 3 June 2025·DOI10.4236/nm.2025.162011
Copy link · social · email
Abstract
We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm ® ). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.
KeywordsSARS-CoV2MyastheniaJAK2
- Chavez, A. and Pougnier, C. (2021) A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis. Journal of Primary Care & Community Health , 12. https://doi.org/10.1177/21501327211051933
- Lee, M.A., Lee, C., Park, J.H. and Lee, J.H. (2022) Early-onset Myasthenia Gravis Following COVID-19 Vaccination. Journal of Korean Medical Science , 37, e50. https://doi.org/10.3346/jkms.2022.37.e50
- Barzilai, O., Ram, M. and Shoenfeld, Y. (2007) Viral Infection Can Induce the Production of Autoantibodies. Current Opinion in Rheumatology , 19, 636-643. https://doi.org/10.1097/bor.0b013e3282f0ad25
- Ramdas, S., Hum, R.M., Price, A., Paul, A., Bland, J., Burke, G., et al. (2022) SARS-CoV-2 Vaccination and New-Onset Myasthenia Gravis: A Report of 7 Cases and Review of the Literature. Neuromuscular Disorders , 32, 785-789. https://doi.org/10.1016/j.nmd.2022.09.001
- Slavin, E., Fitzig, J., Neubert, C., Garcia-Lopez, F. and Cuevas-Trisan, R. (2022) New-onset Myasthenia Gravis Confirmed by Electrodiagnostic Studies after a Third Dose of SARS-CoV-2 mRNA-1273 Vaccine: A Case Report. American Journal of Physical Medicine & Rehabilitation , 101, e176-e179. https://doi.org/10.1097/phm.0000000000002076
- Vadalà, M., Poddighe, D., Laurino, C. and Palmieri, B. (2017) Vaccination and Autoimmune Diseases: Is Prevention of Adverse Health Effects on the Horizon? EPMA Journal , 8, 295-311. https://doi.org/10.1007/s13167-017-0101-y
- Finsterer, J. (2021) Neurological Side Effects of SARS-CoV-2 Vaccinations. Acta Neurologica Scandinavica , 145, 5-9. https://doi.org/10.1111/ane.13550
- Abna, Z., Khanmoradi, Z. and Abna, Z. (2022) A New Case of Myasthenia Gravis Following COVID-19 Vaccination. Neuroimmunology Reports , 2, Article ID: 100128. https://doi.org/10.1016/j.nerep.2022.100128
- Mungmunpuntipantip, R. and Wiwanitkit, V. (2022) Acute Onset Ocular Myasthenia Gravis after COVID-19 Vaccination: Correspondence. Orbit , 41, 661-661. https://doi.org/10.1080/01676830.2022.2079677
- Maher, D.I., Hogarty, D. and Ben Artsi, E. (2022) Response to Letter to the Editor Regarding “Acute Onset Ocular Myasthenia Gravis after Vaccination with the Oxford-Astrazeneca COVID-19 Vaccine”. Orbit , 41, 662-663. https://doi.org/10.1080/01676830.2022.2087234
- Galassi, G., Rispoli, V., Iori, E., Ariatti, A. and Marchioni, A. (2022) Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The Israel Medical Association Journal , 24, 9-10.